Tekla Selling General Administrative from 2010 to 2024

HQL Stock  USD 13.76  0.01  0.07%   
Tekla Life Selling General Administrative yearly trend continues to be quite stable with very little volatility. The value of Selling General Administrative is projected to decrease to about 692 K. From the period between 2010 and 2024, Tekla Life, Selling General Administrative regression line of its data series had standard deviation of  284,154 and standard deviation of  284,154. View All Fundamentals
 
Selling General Administrative  
First Reported
2006-09-30
Previous Quarter
1.4 K
Current Value
1.4 K
Quarterly Volatility
1.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tekla Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tekla Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 M, Interest Expense of 0.0 or Total Revenue of 28.4 M, as well as many indicators such as Price To Sales Ratio of 15.52, Dividend Yield of 0.0452 or PTB Ratio of 0.71. Tekla financial statements analysis is a perfect complement when working with Tekla Life Valuation or Volatility modules.
  
Check out the analysis of Tekla Life Correlation against competitors.

Latest Tekla Life's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Tekla Life Sciences over the last few years. It is Tekla Life's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tekla Life's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Tekla Selling General Administrative Regression Statistics

Arithmetic Mean707,194
Geometric Mean634,863
Coefficient Of Variation40.18
Mean Deviation233,075
Median751,317
Standard Deviation284,154
Sample Variance80.7B
Range886.7K
R-Value0.70
Mean Square Error44.4B
R-Squared0.49
Significance0
Slope44,458
Total Sum of Squares1.1T

Tekla Selling General Administrative History

2024692 K
2023M
2022903.1 K
20211.1 M
2020844 K
2019751.3 K
2018876.8 K

About Tekla Life Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Tekla Life income statement, its balance sheet, and the statement of cash flows. Tekla Life investors use historical funamental indicators, such as Tekla Life's Selling General Administrative, to determine how well the company is positioned to perform in the future. Although Tekla Life investors may use each financial statement separately, they are all related. The changes in Tekla Life's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tekla Life's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Tekla Life Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Tekla Life. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling General AdministrativeM692 K

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Tekla Life Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Information and Resources on Investing in Tekla Stock

When determining whether Tekla Life Sciences is a strong investment it is important to analyze Tekla Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tekla Life's future performance. For an informed investment choice regarding Tekla Stock, refer to the following important reports:
Check out the analysis of Tekla Life Correlation against competitors.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.66)
Dividend Share
1.3
Earnings Share
0.79
Revenue Per Share
0.134
Quarterly Revenue Growth
0.344
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.